Department of Pediatrics, Division of General Pediatrics, Hamad Medical Corporation, Doha, Qatar.
Int J Gen Med. 2014 Jul 25;7:389-91. doi: 10.2147/IJGM.S66550. eCollection 2014.
Bartter syndrome is an autosomal recessive disease manifested by a defect in chloride transport in the thick loop of Henle, with different genetic origins and molecular pathophysiology. Children with Bartter syndrome generally present in early infancy with persistent polyuria and associated dehydration, electrolyte imbalance, and failure to thrive. Although early diagnosis and appropriate treatment of Bartter syndrome may improve the outcome, some children will progress to renal failure. We report a case of an 8-week-old infant who was admitted for electrolyte imbalance and failure to thrive. Laboratory studies revealed hypochloremic metabolic alkalosis with severe hypokalemia. Health care providers should consider Bartter syndrome when excessive chloride losses appear to be renal in origin and the patient has normal blood pressure and high levels of serum renin and aldosterone. Treatments, including indomethacin, spironolactone, and aggressive fluid and electrolyte replacement, may prevent renal failure in children with Bartter syndrome. Molecular genetics studies are indicated to identify the primary genetic defect.
巴特综合征是一种常染色体隐性遗传病,表现为亨利袢升支粗段氯离子转运缺陷,具有不同的遗传起源和分子病理生理学机制。巴特综合征患儿一般在婴儿早期出现持续多尿和相关脱水、电解质失衡以及生长发育不良。尽管早期诊断和适当的巴特综合征治疗可能改善预后,但一些患儿会进展为肾衰竭。我们报告了一例 8 周龄婴儿,因电解质失衡和生长发育不良入院。实验室研究显示低氯性代谢性碱中毒伴严重低钾血症。当氯丢失似乎源于肾脏且患者血压正常、血清肾素和醛固酮水平升高时,医护人员应考虑巴特综合征。包括吲哚美辛、螺内酯和积极的液体及电解质替代在内的治疗方法可能预防巴特综合征患儿的肾衰竭。应进行分子遗传学研究以确定主要遗传缺陷。